The opening of our second unit makes Richmond Pharmacology the largest phase I CRO in the UK. Our total capacity across the two sites has increased to 90 beds.
In December we commenced what is believed to be the first ever festive chocolate-based early phase trial. The trial was based around a self-administered programme delivered in an advent calendar package. Our volunteers were encouraged to respond via e-CRF on our website, and the results are now in.
After careful consideration of the response and thorough checking of the data, we can now reveal the findings
We are proud to announce that Claire Tucker, Business Development Manager, has been named the Sales Professional of the Year: Pharmaceutical and Healthcare at the prestigious National Sales Awards 2004. This is unqualified recognition of Claire’s professionalism and tenacity in a completely new and competitive field.
Spring has been a busy time for Richmond Pharmacology with exhibition presence at two major industry events: the Drug Information Association’s 16th Annual EuroMeeting and the Institute of Clinical Research’s 25th Annual Spring Meeting and Exhibition.
The EU Clinical Trials Directive is set to become part of the UK’s regulatory and legal landscape from 1 May, 2004. Richmond Pharmacology has produced a guide to how the directive will impact on research projects, timelines and approval systems.
Four Richmond Pharmacology managers braved the recent 10k Capital FM Bupa Featbeat fun run through Hyde Park! Sarah Willison, Victoria Blades, Chris Robinson and Sian Dale took part in the fund raising event, held on 23 May 2004.
Richmond Pharmacology is delighted to announce we recruited over 7,000 new volunteers between January and March of 2004. This takes the total number of volunteers registered to over 25,000 in just 2 years.
RPL is delighted to welcome Clinical Trials Assistant, Bibbi Jilka back to the company after a short spell at Parexel.
The newest addition to our sophisticated range of technologies is the highly accurate and reliable blood pressure measuring device, the Finometer.
As you are aware the EU Clinical Trials Directive has become part of the UK's regulatory and legal landscape from 1 May, 2004. Richmond Pharmacology has welcomed the directive which will help to harmonise trial standards across the board.
To thank everyone at Richmond Pharmacology for their contribution to our continued growth and success, RPL held a Staff Fun Day in London, including a trip on the London Eye.
Our Managing Director Dr Jörg Täubel and Medical Director Dr Ulrike Lorch recently travelled to Japan to meet with business partners and learnt more about the Japanese way of doing business.
Richmond Pharmacology's (RPL's) highly successful business team has recently undergone a re-organisation to enhance the outstanding service we provide to our valued clients.
Excitement is mounting at Richmond Pharmacology as we approach the QTc workshop to be held on 29th September 2004 at St George's Hospital Medical School. The workshop has received much interest and is expected to be a huge success.
Today we are celebrating after successfully recruiting our 30,000th clinical trial volunteer. This major milestone has been reached in just two and a half years, demonstrating that we continue to lead the market in volunteer recruitment.
The QTc workshop hosted by Richmond Pharmacology on 29th September was deemed a huge success. Representatives from top pharmaceutical companies gathered at St George's Hospital to enjoy first class seminars given by world leading experts in cardiology.
Richmond Pharmacology's new dedicated Japanese recruitment team have successfully delivered 2 Japanese panels for Bridging Studies in November and December this year. We are already ahead of target for our Japanese/Caucasian Bridging Studies requirements in 2005.